AQST
Aquestive Therapeutics (AQST)
$19
About Aquestive Therapeutics (AQST)
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.
Details
Daily high
$2.58
Daily low
$2.12
Price at open
$2.56
52 Week High
$5.80
52 Week Low
$2.12
Market cap
283.1M
Dividend yield
0.00%
Volume
8.0M
Avg. volume
991,167
P/E ratio
-5.50
Aquestive Therapeutics News
Details
Daily high
$2.58
Daily low
$2.12
Price at open
$2.56
52 Week High
$5.80
52 Week Low
$2.12
Market cap
283.1M
Dividend yield
0.00%
Volume
8.0M
Avg. volume
991,167
P/E ratio
-5.50